C.S. Group is redefining the Taiwanofungus Camphoratus landscape by transitioning the species from a traditional supplement to a novel veterinary pharmaceutical, integrated with an innovative brick-and-mortar retail chain model. This evolution represents more than mere product innovation; it marks a significant milestone in the globalization of Taiwan’s biotechnology sector and sets a new paradigm for the commercial application of Taiwan’s unique fungal resources.